Measuring therapeutic alliance between oncologists and patients with advanced cancer

2009177 citationsJournal Articlebronze Open Access

Authors

Jennifer W. Mack · Dana-Farber Cancer Institute

Susan D. Block · Dana-Farber Cancer Institute

Matthew Nilsson · Dana-Farber Cancer Institute

Alexi A. Wright · Dana-Farber Cancer Institute

E. D. Trice · Dana-Farber Cancer Institute

Robert J. Friedlander · New Hampshire Hospital

Elizabeth Paulk

Abstract

The THC scale is a valid and reliable measure of therapeutic alliance between patients with advanced cancer and their physicians. In addition, there was no evidence to suggest that EOL discussions harm patients' therapeutic alliance. A strong therapeutic alliance was associated with emotional acceptance of a terminal illness and with decreased ICU care at the EOL among patients with advanced cancer.

Topics & Keywords

Palliative Care and End-of-Life Issues Patient-Provider Communication in Healthcare Patient Dignity and Privacy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 115, Issue 14, pp. 3302-3311

DOI: 10.1002/cncr.24360

Field-Weighted Citation Impact: 4.91